First Public Disclosure of the Environmental Impact Assessment for the Phase I Project of Minhai Biotechnology’s International Vaccine Industrial Base

Release date:

2019-01-25

Author:

Source:


Abstract

(1) Project Name: Minhai Biologics’ Internationalization Industrial Base for Novel Vaccines (Phase I) (2) Site Location: Plots 053-039, 040, 043, and 044 within the Daxing Biopharmaceutical Industry Base of the Zhongguancun Science Park, Daxing District, Beijing; bounded by Tianfu Avenue to the east, the planned land‑use boundary to the south, Xiangrui Avenue to the west, and Simiao Road to the north. (3) Construction Scope: The project covers a land area of 90,013.218 m², with a total above‑ground floor area of 135,020 m²; a floor area ratio of 1.5; a building density of 40%; a green space ratio of 15%; and a height restriction of 36 meters. The facility will have an annual production capacity of inactivated adsorbed acellular DPT–IPV vaccine.

(1) Project Name: Minhai Biologics Internationalization Industrial Base for Novel Vaccines (Phase I) Project

(II) Site Selection: Daxing Biopharmaceutical Industry Base, Zhongguancun Science Park, Daxing District, Beijing 053-039 040043044 The parcel is bounded by Tianfu Avenue to the east, the planned land-use boundary to the south, Xiangrui Avenue to the west, and Simiao Road to the north.

(3) Project Scope: Project Land Area 90013.218m2 , the scale of above-ground buildings 135020m2 ; Floor Area Ratio 1.5 ; Building density 40% ; Green space ratio 15% ; Control altitude 36 m. Annual production of adsorbed acellular diphtheria–tetanus–pertussis, inactivated poliovirus, and… b Haemophilus influenzae type b conjugate vaccine 2000 Ten doses; pneumococcal conjugate vaccine 2500 Ten doses; MMRV vaccine series: live attenuated combined measles–mumps–rubella–varicella vaccine 2000 Ten-dose, live attenuated combined measles-mumps-rubella-varicella vaccine 500 Ten doses of freeze-dried live attenuated varicella vaccine 1000 Ten thousand doses.

(4) Name of the Construction Entity: Beijing Minhai Biotechnology Co., Ltd.

Contact: Xia Zhanxiong

Contact phone number: 010-59613634

Email: xiazhanxiong@biominhai.com

(5) Environmental Impact Assessment Report Preparation Unit: Puhua Holdings Co., Ltd.

(6) Online link to the public comment form: http://www.biominhai.com/xwzx_xi/newsId=347.html

(7) Methods and channels for submitting public comments.

Phone: 010-59613634

Email: xiazhanxiong@biominhai.com

During the preparation of the draft environmental impact assessment report, the public may submit comments related to the environmental impact assessment to the project proponent.

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09